Plasmapp Co Ltd

Plasmapp Co Ltd has a price-to-book ratio of 5.16 and a price-to-tangible-book ratio of 5.16, indicating that the market is valuing the company's equity at a premium relative to its book value. The company's liquidity position is characterized by a current ratio of 1.1, suggesting that it has just enough current assets to cover its current liabilities. However, the company's operating cash flow is negative at -4521800890.0 KRW, and its free cash flow is also negative at -5559283680.0 KRW, indicating that it is not generating sufficient cash from operations to fund its activities. In terms of profitability, Plasmapp Co Ltd is currently unprofitable, with a net income of -6586889600.0 KRW and an operating income of -5248750560.0 KRW. The company's return on equity is -1.1516, and its return on assets is -0.3205, both of which are negative, indicating that it is not generating returns for its shareholders or effectively utilizing its assets. The company's debt-to-equity ratio is 1.64, suggesting that it is using a significant amount of debt to finance its operations. Plasmapp Co Ltd's revenue is concentrated in its core business of providing medical solutions, with no significant diversification across segments or geographies. The company's revenue is primarily generated from the sale of sterilizers, sterile consumables, regenerative activators, and accessories. There is no indication of significant geographic diversification in the company's revenue. The company's growth trajectory is currently negative, with a net income of -6586889600.0 KRW and an operating income of -5248750560.0 KRW. The company's revenue is 8482954610.0 KRW, but it is not clear whether this represents growth or a decline from previous periods. The company's capital expenditure is -279392710.0 KRW, indicating that it is not investing in new projects or expanding its operations. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of net cash being negative after subtracting total debt suggests that the company may have difficulty meeting its short-term obligations. The company's dilution potential is low, indicating that it is not likely to issue additional shares that would dilute existing shareholders' ownership. The company's debt-to-equity ratio of 1.64 suggests that it is using a significant amount of debt to finance its operations, which could increase its financial risk. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile are based on the latest available data, and there is no indication of any recent developments that would significantly impact its business.